These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9331009

  • 21. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H, Ogihara T.
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D, Porteri E, De Ciuceis C, Sleiman I, Rodella L, Rezzani R, Paiardi S, Bianchi R, Ruggeri G, Boari GE, Muiesan ML, Salvetti M, Zani F, Miclini M, Rosei EA.
    Hypertension; 2005 Apr; 45(4):659-65. PubMed ID: 15723969
    [Abstract] [Full Text] [Related]

  • 24. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G, Fuchs W.
    Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R, Wada T, Sanada T, Ojima M, Inada Y.
    Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
    [Abstract] [Full Text] [Related]

  • 27. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension.
    Hoy SM, Keating GM.
    Am J Cardiovasc Drugs; 2010 Mar; 10(5):335-42. PubMed ID: 20860416
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
    Plouin PF.
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
    [No Abstract] [Full Text] [Related]

  • 30. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C.
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract] [Full Text] [Related]

  • 31. Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Barrios V, Escobar C.
    Expert Opin Drug Saf; 2011 Nov; 10(6):957-68. PubMed ID: 21848481
    [Abstract] [Full Text] [Related]

  • 32. The CHARM programme raises the profile of candesartan cilexetil in the treatment of chronic health failure.
    Cardiovasc J S Afr; 2004 Nov; 15(1):42-3. PubMed ID: 15095753
    [No Abstract] [Full Text] [Related]

  • 33. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA.
    Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract] [Full Text] [Related]

  • 34. A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension.
    Mimran A, Ruilope L, Kerwin L, Nys M, Owens D, Kassler-Taub K, Osbakken M.
    J Hum Hypertens; 1998 Mar 24; 12(3):203-8. PubMed ID: 9579771
    [Abstract] [Full Text] [Related]

  • 35. Candesartan cilexetil induced pustular psoriasis.
    Kawamura A, Ochiai T.
    Eur J Dermatol; 2003 Mar 24; 13(4):406-7. PubMed ID: 12948927
    [Abstract] [Full Text] [Related]

  • 36. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR, Chen CH, Ding PY, Chen YT, Ting CT, Huang JL, Chiang AH, Liu CP, Tseng CJ, Chao CT, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May 24; 63(5):368-76. PubMed ID: 10862446
    [Abstract] [Full Text] [Related]

  • 37. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Noda M, Matsuo T, Fukuda R, Ohta M, Nagano H, Shibouta Y, Naka T, Nishikawa K, Imura Y.
    Kidney Int; 1999 Sep 24; 56(3):898-909. PubMed ID: 10469358
    [Abstract] [Full Text] [Related]

  • 38. Preserving target-organ function with candesartan cilexetil in patients with hypertension.
    Zannad F.
    Blood Press Suppl; 2000 Sep 24; 1():36-9. PubMed ID: 11059635
    [Abstract] [Full Text] [Related]

  • 39. Achieving quality 24-h blood pressure control with candesartan cilexetil.
    Meredith P.
    Blood Press Suppl; 2000 Sep 24; 1():23-6. PubMed ID: 11059632
    [Abstract] [Full Text] [Related]

  • 40. Renal protective effect of candesartan cilexetil in spontaneously hypercholesterolemic rats.
    Matsuo T, Ishikawa E, Ohta M, Shibouta Y, Ishimura Y, Imura Y, Sugiyama Y.
    Jpn J Pharmacol; 2002 Mar 24; 88(3):300-6. PubMed ID: 11949885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.